Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Barlocco

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Archiv Der Pharmazie|November 17, 2006
3-heptylamino-5-phenylpyridazine derivatives as analogues of Acyl-CoA: cholesterol acyltransferase inhibitors containing the N-heptyl-N'-arylureidic moietyArianna Gelain, Daniela Barlocco, Byong-Mog Kwon, et al.
Journal of Medicinal Chemistry|November 24, 2005
Mono- or diphenylpyridazines connected to N-(2,4-difluorophenyl)-N'-heptylurea as acyl-CoA:cholesterol acyltransferase inhibitorsArianna Gelain, Ilaria Bettinelli, Daniela Barlocco, et al.
Journal of Medicinal Chemistry|February 21, 2008
Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitorsArianna Gelain, Daniela Barlocco, Byoung-Mog Kwon, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
ortho-Halogen naphthaleins as specific inhibitors of Lactobacillus casei thymidylate synthase. Conformational properties and biological activityStefano Ghelli, Marcella Rinaldi, Daniela Barlocco, et al.
Biochimica Et Biophysica Acta|June 27, 2002
Structure-based studies on species-specific inhibition of thymidylate synthaseM Paola Costi, Donatella Tondi, Marcella Rinaldi, et al.
Journal of Medicinal Chemistry|August 23, 2002
6-Chloropyridazin-3-yl derivatives active as nicotinic agents: synthesis, binding, and modeling studiesLucio Toma, Paolo Quadrelli, William H Bunnelle, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular AgentsMatteo Mori, Giovanni Stelitano, Laurent R Chiarelli, et al.
Chemical Biology & Drug Design|April 19, 2017
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activityFederica Porta, Arianna Gelain, Daniela Barlocco, et al.
Archiv Der Pharmazie|February 22, 2003
Novel 3-arylamino- and 3-cycloalkylamino-5, 6-diphenyl-pyridazines active as ACAT inhibitorsLucio Toma, Maria Paola Giovannoni, Claudia Vergelli, et al.
Molecules (Basel, Switzerland)|June 24, 2018
New Chromane-Based Derivatives as Inhibitors of <i>Mycobacterium tuberculosis</i> Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling StudiesElena Pini, Giulio Poli, Tiziano Tuccinardi, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Archiv Der Pharmazie|November 17, 2006
3-heptylamino-5-phenylpyridazine derivatives as analogues of Acyl-CoA: cholesterol acyltransferase inhibitors containing the N-heptyl-N'-arylureidic moietyArianna Gelain, Daniela Barlocco, Byong-Mog Kwon, et al.
Journal of Medicinal Chemistry|November 24, 2005
Mono- or diphenylpyridazines connected to N-(2,4-difluorophenyl)-N'-heptylurea as acyl-CoA:cholesterol acyltransferase inhibitorsArianna Gelain, Ilaria Bettinelli, Daniela Barlocco, et al.
Journal of Medicinal Chemistry|February 21, 2008
Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitorsArianna Gelain, Daniela Barlocco, Byoung-Mog Kwon, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
ortho-Halogen naphthaleins as specific inhibitors of Lactobacillus casei thymidylate synthase. Conformational properties and biological activityStefano Ghelli, Marcella Rinaldi, Daniela Barlocco, et al.
Biochimica Et Biophysica Acta|June 27, 2002
Structure-based studies on species-specific inhibition of thymidylate synthaseM Paola Costi, Donatella Tondi, Marcella Rinaldi, et al.
Journal of Medicinal Chemistry|August 23, 2002
6-Chloropyridazin-3-yl derivatives active as nicotinic agents: synthesis, binding, and modeling studiesLucio Toma, Paolo Quadrelli, William H Bunnelle, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular AgentsMatteo Mori, Giovanni Stelitano, Laurent R Chiarelli, et al.
Chemical Biology & Drug Design|April 19, 2017
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activityFederica Porta, Arianna Gelain, Daniela Barlocco, et al.
Archiv Der Pharmazie|February 22, 2003
Novel 3-arylamino- and 3-cycloalkylamino-5, 6-diphenyl-pyridazines active as ACAT inhibitorsLucio Toma, Maria Paola Giovannoni, Claudia Vergelli, et al.
Molecules (Basel, Switzerland)|June 24, 2018
New Chromane-Based Derivatives as Inhibitors of <i>Mycobacterium tuberculosis</i> Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling StudiesElena Pini, Giulio Poli, Tiziano Tuccinardi, et al.
Pageof 4